Literature DB >> 32261654

PEGylated poly(amine-co-ester) micelles as biodegradable non-viral gene vectors with enhanced stability, reduced toxicity and higher in vivo transfection efficacy.

Xiaofang Zhang1, Wenxin Tang, Zhe Yang, Xingen Luo, Huiyan Luo, Di Gao, Ya Chen, Qing Jiang, Jie Liu, Zhaozhong Jiang.   

Abstract

Nanosized micelles based on cationic, amphiphilic poly(ethylene glycol)-poly(ω-pentadecalactone-co-N-methyldiethyleneamine-co-sebacate) (PEG-PPMS) block copolymers have been successfully developed to serve as a new type of biodegradable non-viral vectors for DNA delivery. PEG-PPMS copolymers with various compositions were synthesized in one step via lipase-catalyzed copolymerization of ω-pentadecalactone (PDL), N-methyldiethanolamine (MDEA) and diethyl sebacate (DES) with poly(ethylene glycol) methyl ether (MeO-PEG-OH). The effects of PEG molecular weight, PEG and PDL contents on the biological properties (including the gene transfection efficiency) of the copolymer micelles were investigated. The LucDNA-loaded micelles formed from the copolymers with 30-50 wt% PEG showed high stability in serum-containing aqueous medium, which is in sharp contrast to rapid aggregation of LucDNA/PPMS polyplex particles. The conjugation of PEG to PPMS chains significantly reduces the cytotoxicity and hemolysis activity of the PEG-PPMS micelles. Compared to PEG-free PPMS, the micelles of PEG-PPMS copolymers with optimal compositions (e.g., 42%PEG5K-PPMS-10%PDL and 42%PEG5K-PPMS-20%PDL) exhibited enhanced capability to condense and protect DNA. Although the optimized micelles showed comparable or slightly lower gene transfection efficacy than the reference PPMS in vitro, the efficiency of LucDNA/42%PEG5K-PPMS-20%PDL micelles in transfecting tumor cells in mice was twice as high as that of LucDNA/PPMS polyplex particles due to their strong DNA condensation ability and excellent stability under physiological conditions. The PEG-PPMS micelle system with improved properties is a family of potentially promising non-viral vectors for in vivo delivery of therapeutic genes to treat tumors.

Entities:  

Year:  2014        PMID: 32261654     DOI: 10.1039/c4tb00439f

Source DB:  PubMed          Journal:  J Mater Chem B        ISSN: 2050-750X            Impact factor:   6.331


  2 in total

1.  Multiple stimuli-responsive nanosystem for potent, ROS-amplifying, chemo-sonodynamic antitumor therapy.

Authors:  JunJie Tang; Xiaoge Zhang; Lili Cheng; Yadong Liu; You Chen; Zhaozhong Jiang; Jie Liu
Journal:  Bioact Mater       Date:  2021-12-20

2.  Increased antitumor efficacy of ginsenoside Rh2 via mixed micelles: in vivo and in vitro evaluation.

Authors:  Xiaojing Xia; Jin Tao; Zhuwa Ji; Chencheng Long; Ying Hu; Zhiying Zhao
Journal:  Drug Deliv       Date:  2020-12       Impact factor: 6.419

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.